Microsoft India has announced its partnership with SRL diagnostics to expand its existing AI (Artificial Intelligence) network for healthcare to pathology to detect cancer.
The collaboration is bringing Microsoft’s Azure and AI innovations and SRL’s expertise in the study of cells and tissues together. It would improve the quality of digital pathology.
“Microsoft is committed to empower both the healthcare industry and patients by using AI to democratise healthcare for all. Our partnership with SRL Diagnostics will assist pathologists by equipping them with technology that will augment their capability,” said Anil Bhansali, Managing Director, Microsoft India (R&D) Pvt Ltd in a statement.
Microsoft will also build an AI platform to create a software environment using SRL’s repository of more than a million histopathology slides.
“Diagnosis is the first step to disease management. Without accurate identification of the cause, there is no possibility of a precise treatment. With the growing number of samples of cancer, as well as of other diseases, there’s a need to quickly and accurately analyse the samples to help doctors arrive at a diagnosis faster,” said Arindam Haldar, Chief Executive Officer, SRL Diagnostics.
AI network will promote innovation in the healthcare industry and improve the lives of people around the world.
In past as well, Microsoft had also applied AI for early detection of diabetic retinopathy to prevent blindness and an AI-powered Cardiovascular Disease Risk Score API (Application programme interface).